Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

THE EFFECTS OF MIRABEGRON AND TAMSULOSIN FOR PATIENTS WITH URETERAL STENTS

NCT06124066 is registered in ClinicalTrials.gov with Hasanuddin University as lead sponsor.

NCT NCT06124066
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06124066 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
THE EFFECTS OF MIRABEGRON AND TAMSULOSIN FOR PATIENTS WITH URETERAL STENTS
Lead sponsor
Hasanuddin University
Phase
Phase 4
Overall status
Completed
Start date
July 1, 2022
Completion date
October 30, 2022
Enrollment
42 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

kidney stones, ureteral stenosis, ureteral stone